- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Kits
Snapshot for BG Medicine Inc (BGMD)
| Open: | 1.7900 | Day's Range: | 1.7100 - 1.7900 | Volume: | 92,707 |
|---|---|---|---|---|---|
| Previous Close: | 1.7200 | 52wk Range: | 1.0000 - 7.1000 | 1-Yr Rtn: | -60.00% |
Key Statistics for BGMD
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.9800 |
| Est. EPS (USD) (12/2013) | -0.7670 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 47.43 |
| Shares Outstanding (M) | 27.58 |
| 30 Day Average Volume | 118,323 |
| Price/Book (mrq) | 5.6611 |
| Price/Sale (ttm) | 11.4742 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BGMD
Company Profile & Key Executives for BGMD
BG Medicine, Inc. develops and markets diagnostic tests. The Company develops biomarkers that predict a patient's response to a drug therapy, determine the potential toxicity of therapeutic agents to patients, identify patients who have or are likely to develop a specific disease, predict a patient's prognosis once a disease has been diagnosed, and monitor a patient's disease progression.
| Stephane BancelChairman | Paul R SohmerPresident/CEO |
| Charles H Abdalian Jr "Chuck"Exec VP/CFO/Treasurer | Aram AdourianSenior VP/Chief Scientific Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BGMD News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page